𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lamivudine vs lamivudine and interferon combination treatment of HBeAg(−) chronic hepatitis B

✍ Scribed by C. Yurdaydin; H. Bozkaya; H. Çetinkaya; T. Şahin; D. Karaoğuz; M. Törüner; Ö. Erkan; A. O. Heper; E. Erden; A. M. Bozdayi; Ö. Uzunalimoğlu

Book ID
108885740
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
84 KB
Volume
12
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of interferon and lamivudine
Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B
✍ Yasuji Arase; Kenji Ikeda; Fumitaka Suzuki; Yoshiyuki Suzuki; Masahiro Kobayashi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract The aim of this study was to elucidate the long‐term outcome after interferon (IFN) or lamivudine (LMV) treatment in Japanese patients with hepatitis B e antigen (HBeAg) positive chronic hepatitis B. Inclusion criteria were biopsy proven chronic hepatitis or liver cirrhosis, no history

Efficacy of lamivudine in HBeAg-negative
Efficacy of lamivudine in HBeAg-negative chronic hepatitis B
✍ Mario Rizzetto 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

## Abstract Hepatitis B e antigen (HBeAg)‐negative chronic hepatitis B results from infection with hepatitis B virus mutants unable to produce HBeAg. It accounts for 7–30% of patients with chronic hepatitis B virus (HBV) worldwide, with the highest rates reported for Mediterranean Europe and Asia.

Long-term follow-up of peginterferon and
Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B
✍ Henry Lik-Yuen Chan; Alex Yui Hui; Vincent Wai-Sun Wong; Angel Mei-Ling Chim; Ma 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

We have previously demonstrated that combination peginterferon and lamivudine treatment has superior antiviral efficacy to lamivudine monotherapy in chronic hepatitis B. In this study, we investigated the long-term posttreatment virological response to this combination treatment. Sustained virologic